Cargando…
Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
Insulinoma is a rare pancreatic neuroendocrine tumor. Overproduction of insulin and associated hypoglycemia are hallmark features of this disease. Diagnosis can be made through demonstration of hypoglycemia and elevated plasma levels of insulin or C-Peptide. Metastatic disease can be detected throug...
Autores principales: | Costa, Ricardo, Costa, Rubens, Bacchi, Carlos E., Almeida Filho, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877610/ https://www.ncbi.nlm.nih.gov/pubmed/24455330 http://dx.doi.org/10.1155/2013/252159 |
Ejemplares similares
-
Metastatic Malignant Paraganglioma Presenting as a Neck Mass Treated with Radiolabeled Somatostatin Analog
por: Jehangir, Waqas, et al.
Publicado: (2021) -
A case of malignant insulinoma responsive to somatostatin analogs treatment
por: Caliri, Mariasmeralda, et al.
Publicado: (2018) -
A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs
por: Crespo-Jara, Aurora, et al.
Publicado: (2016) -
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020) -
Effects of somatostatin analogs on uptake of radiolabeled somatostatin analogs on imaging: a systematic review and meta-analysis
por: Wang, Rang, et al.
Publicado: (2023)